Abstract
LBO-02 - Safety and efficacy of VIR-2218 with or without pegylated interferon alfa in virally-suppressed participants with chronic hepatitis B virus infection: post-treatment follow-up
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have